Evaluation of linagliptin and insulin combined therapy on unfolded protein response in type 1 diabetic mouse heart.

Doganyigit, Züleyha; Okan, Asli; Taheri, Serpil; Yilmaz, Zeynep; Akyüz, Enes; Demir, Necdet

Doganyigit, Züleyha; Okan, Asli; Taheri, Serpil; Yilmaz, Zeynep; Akyüz, Enes; Demir, Necdet.

Afiliação

Doganyigit Z; Faculty of Medicine, Department of Histology and Embryology, Yozgat Bozok University, Yozgat, Turkey.
Okan A; Faculty of Medicine, Department of Histology and Embryology, Yozgat Bozok University, Yozgat, Turkey.
Taheri S; Faculty of Medicine, Department of Medical Biology, Erciyes University, Kayseri, Turkey.
Yilmaz Z; Faculty of Medicine, Department of Medical Biology, Erciyes University, Kayseri, Turkey.
Akyüz E; Faculty of International Medicine, Department of Biophysics, University of Health Sciences, Istanbul, Turkey.
Demir N; Faculty of Medicine, Department of Histology and Embryology, Akdeniz University, Antalya, Turkey.

Chem Biol Drug Des ; 102(5): 1085-1096, 2023 11.

Article em En | MEDLINE | ID: mdl-37532256

Assuntos

Diabetes Mellitus Tipo 1; Inibidores da Dipeptidil Peptidase IV; Camundongos; Animais; Feminino; Linagliptina/farmacologia; Linagliptina/uso terapêutico; Insulina; Caspase 3; Diabetes Mellitus Tipo 1/tratamento farmacológico; Inibidores da Dipeptidil Peptidase IV/farmacologia; Inibidores da Dipeptidil Peptidase IV/uso terapêutico; Resposta a Proteínas não Dobradas; RNA Mensageiro

Palavras-chave

DPP-4 inhibitor; linagliptin; mouse; type 1 diabetes mellitus; unfolded protein response

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Inibidores da Dipeptidil Peptidase IV Limite: Animals Idioma: En Revista: Chem Biol Drug Des Assunto da revista: BIOQUIMICA / FARMACIA / FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google